CacheTech Inc. Grows Position in Humana Inc. (NYSE:HUM)

CacheTech Inc. lifted its holdings in shares of Humana Inc. (NYSE:HUM) by 5.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,818 shares of the insurance provider’s stock after purchasing an additional 422 shares during the quarter. CacheTech Inc.’s holdings in Humana were worth $2,476,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. CarsonAllaria Wealth Management Ltd. raised its position in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Creative Financial Designs Inc. ADV boosted its stake in Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after buying an additional 61 shares in the last quarter. Atwood & Palmer Inc. bought a new position in Humana during the third quarter valued at approximately $29,000. Hantz Financial Services Inc. purchased a new position in shares of Humana during the second quarter worth approximately $35,000. Finally, Family Firm Inc. purchased a new stake in shares of Humana in the 2nd quarter valued at $37,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Trading Up 1.1 %

Humana stock opened at $260.71 on Friday. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $527.18. The company has a market capitalization of $31.39 billion, a price-to-earnings ratio of 23.09, a price-to-earnings-growth ratio of 2.07 and a beta of 0.50. The business’s fifty day simple moving average is $297.06 and its two-hundred day simple moving average is $334.38. The company has a current ratio of 1.76, a quick ratio of 1.66 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, equities analysts predict that Humana Inc. will post 16.06 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.36%. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Analysts Set New Price Targets

HUM has been the topic of a number of analyst reports. Leerink Partners cut shares of Humana from an “outperform” rating to a “market perform” rating and decreased their target price for the stock from $400.00 to $250.00 in a research report on Wednesday, October 2nd. Royal Bank of Canada decreased their price objective on Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. TD Cowen lowered Humana from a “buy” rating to a “hold” rating and lowered their target price for the company from $402.00 to $261.00 in a research note on Monday, October 7th. UBS Group lowered their price objective on Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, October 4th. Finally, Piper Sandler downgraded shares of Humana from an “overweight” rating to a “neutral” rating and lowered their price objective for the company from $392.00 to $274.00 in a research note on Thursday, October 3rd. One investment analyst has rated the stock with a sell rating, nineteen have given a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $315.48.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.